We are live on
!
Find out more
HWM
HighMark Wealth Management Portfolio holdings
AUM
$246M
1-Year Est. Return
35.95%
This Fund
S&P 500
This Quarter
Est. Return
-4.21%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$121M
AUM Growth
-$12.5M
(-9.4%)
Cap. Flow
-$6.4M
Cap. Flow
% of AUM
-5.31%
Top 10 Holdings %
Top 10 Hldgs %
74.38%
Holding
590
New
27
Increased
162
Reduced
81
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Protolabs
PRLB
|
+$145K |
| 2 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
+$111K |
| 3 |
AtriCure
ATRC
|
+$87.8K |
| 4 |
Tandem Diabetes Care
TNDM
|
+$78.8K |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$67.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$2.16M |
| 2 |
Krystal Biotech
KRYS
|
+$2.02M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$637K |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$584K |
| 5 |
Halozyme
HALO
|
+$430K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.9% |
| 2 | Financials | 4.48% |
| 3 | Technology | 3.39% |
| 4 | Consumer Discretionary | 2.75% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Globant
GLOB
$1.52B
| $108K | 0.09% |
547
| – | – |
|
77
Webster Financial
WBS
$12.5B
| $108K | 0.09% |
2,683
+24
| +0.9% | +$1.02K |
|
78
Visa
V
$697B
| $106K | 0.09% |
463
| – | – |
|
79
CoStar Group
CSGP
$12.4B
| $101K | 0.08% |
1,317
| – | – |
|
80
IBM
IBM
$214B
| $99K | 0.08% |
706
+8
| +1% | +$1.14K |
|
81
Workday
WDAY
$39.4B
| $98.6K | 0.08% |
459
| – | – |
|
82
State Street SPDR S&P Bank ETF
KBE
$1.66B
| $97.8K | 0.08% |
2,655
-116
| -4% | -$4.52K |
|
83
Caterpillar
CAT
$387B
| $96K | 0.08% |
352
| – | – |
|
84
State Street Energy Select Sector SPDR ETF
XLE
$38.3B
| $95.9K | 0.08% |
2,122
+570
| +37% | +$24.9K |
|
|
BCYC
85
Bicycle Therapeutics
BCYC
$275M
| $89.1K | 0.07% |
4,435
+200
| +5% | +$4.57K |
|
86
Veeva Systems
VEEV
$32.7B
| $88.7K | 0.07% |
436
| – | – |
|
|
PYCR
87
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $88.2K | 0.07% |
3,865
| – | – |
|
88
Mastercard
MA
$497B
| $86.1K | 0.07% |
217
| – | – |
|
|
ANSS
89
DELISTED
Ansys
ANSS
| $85.1K | 0.07% |
286
| – | – |
|
90
Idexx Laboratories
IDXX
$44.9B
| $84K | 0.07% |
192
| – | – |
|
91
Tyler Technologies
TYL
$13.7B
| $83K | 0.07% |
215
| – | – |
|
92
iShares Morningstar Mid-Cap ETF
IMCB
$1.67B
| $77.5K | 0.06% |
1,297
| – | – |
|
93
iShares MSCI ACWI ETF
ACWI
$32.5B
| $76.4K | 0.06% |
828
+236
| +40% | +$22.6K |
|
94
RB Global
RBA
$21.7B
| $75.3K | 0.06% |
1,205
| – | – |
|
95
Alibaba
BABA
$276B
| $73.7K | 0.06% |
850
+700
| +467% | +$64.1K |
|
96
Valero Energy
VLO
$88.7B
| $72.2K | 0.06% |
509
+50
| +11% | +$6.55K |
|
97
CVS Health
CVS
$140B
| $71.7K | 0.06% |
1,027
+108
| +12% | +$7.65K |
|
98
Cisco
CSCO
$456B
| $71K | 0.06% |
1,321
+134
| +11% | +$7.23K |
|
99
Home Depot
HD
$343B
| $69.9K | 0.06% |
231
| – | – |
|
|
MIRO
100
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
| $68.1K | 0.06% |
51,972
| – | – |
|
Similar funds
PPA
IRP
EPIM
MAMHA
RPCONE
CSC
NTCM
VPA
HighMark Wealth Management's Q3 2023 Portfolio in Review
As of Q3 2023, HighMark Wealth Management held 590 positions worth $121M, down 9.4% from $133M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
HighMark Wealth Management withdrew a net $6.4M in Q3 2023, closing 24 positions and reducing 81 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $2.16M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.9% of assets, down from 12% a quarter earlier, followed by Financials and Technology.
Against the trend, HighMark Wealth Management opened a new position in Insulet worth $19.9K.
- HighMark Wealth Management's largest Q3 2023 buy was Insulet: 125 shares worth $19.9K.
- HighMark Wealth Management added most to Protolabs in Q3 2023, an estimated $145K increase.
- HighMark Wealth Management's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $637K.
- HighMark Wealth Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $2.16M.
- HighMark Wealth Management's ten largest holdings make up 74% of its $121M portfolio in Q3 2023.
- HighMark Wealth Management opened 27 new positions and closed 24 in Q3 2023.
- HighMark Wealth Management's portfolio value fell 9.4% quarter-over-quarter to $121M.
Based on HighMark Wealth Management's 13F filing for Q3 2023, filed 18 Oct 2023.